ESG Report

Overview

The report describes BAP Pharma's 2024 GHG inventory of 47,933 tonnes CO2e on a market-based basis, alongside expanded environmental reporting and decarbonisation planning. It records full CDP corporate disclosure, an EcoVadis score of 73/100 in the 90th percentile, and continued ISO 14001 and ISO 9001 certification. Community and biodiversity initiatives included diverting 620kg of meadow cut material into garden compost and planting 200 hedge saplings.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services